Vyne Therapeutics Inc (NASDAQ:VYNE)

0.2232
Delayed Data
As of 1:59pm ET
 -0.0061 / -2.66%
Today’s Change
0.22
Today|||52-Week Range
1.75
-78.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$13.3M

Company Description

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.

Contact Information

VYNE Therapeutics, Inc.
685 Route 202-206
Bridgewater New Jersey 08807
P:(800) 755-7936
Investor Relations:

Employees

Shareholders

Other institutional9.70%
Individual stakeholders9.29%
Mutual fund holders5.13%

Top Executives

David DomzalskiPresident, Chief Executive Officer & Director
Tyler ZerondaChief Financial Officer & Treasurer
Iain A. StuartChief Scientific Officer
Ray SteitzSenior Vice President-Human Resources
Mutya HarschSecretary, Chief Legal Officer & General Counsel